This company seems to have been delisted
Reason: Acquired by Neuphoria Therapeutics
Last recorded trade on: February 25, 2025
Source: https://www.nasdaq.com/articles/neuphoria-therapeutics-inc-completes-scheme-arrangement-bionomics-limiteds-re
Reason: Acquired by Neuphoria Therapeutics
Last recorded trade on: February 25, 2025
Source: https://www.nasdaq.com/articles/neuphoria-therapeutics-inc-completes-scheme-arrangement-bionomics-limiteds-re
Bionomics
BNOX
$0.40
Share price
4.59%
Change (1 day)
-74.62%
Change (1 year)
Categories
Revenue for Bionomics (BNOX)
Revenue in 2024 (TTM): A$1.06 Million
According to Bionomics's latest financial reports the company's current revenue (TTM 
) is A$1.03 Million. In 2023 the company made a revenue of A$0.02 Million.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Bionomics from 2001 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | A$1.06 M | 4732.67% |
| 2023 | A$0.02 M | |
| 2021 | N/A | -100% |
| 2020 | A$0.04 M | -98.78% |
| 2019 | A$3.82 M | 1.89% |
| 2018 | A$3.75 M | -30.18% |
| 2017 | A$5.37 M | -23.02% |
| 2016 | A$6.98 M | 5.34% |
| 2015 | A$6.62 M | -65.37% |
| 2014 | A$19.14 M | 1069.19% |
| 2013 | A$1.63 M | 45.39% |
| 2012 | A$1.12 M | -64.62% |
| 2011 | A$3.18 M | 6.34% |
| 2010 | A$2.99 M | -17.09% |
| 2009 | A$3.61 M | 220.65% |
| 2008 | A$1.12 M | 37.77% |
| 2007 | A$0.81 M | 25.28% |
| 2006 | A$0.65 M | 120.73% |
| 2005 | A$0.29 M | |
| 2004 | N/A | -100% |
| 2003 | A$1.02 M | -36.2% |
| 2002 | A$1.61 M | 169.05% |
| 2001 | A$0.59 M |